Conteúdo do artigo principal

Autores

Nos doentes com DMD, a capacidade de andar é gradualmente reduzida até à perda da marcha por volta dos 9 anos de idade. Embora a progressão da doença seja inevitável, uma reabilitação abrangente tem como objetivo prolongar a função motora grossa e manual, minimizar as contraturas, promover a saúde óssea, proteger o posicionamento correto da coluna vertebral e prolongar a marcha, melhorando a qualidade de vida e a transição para a adolescência e a idade adulta. As intervenções de reabilitação para a DMD incluem a utilização de ortóteses e cadeiras de rodas. Materiais e métodos: Foi constituído um painel de peritos com conhecimentos e experiência no tratamento de doentes com distrofia muscular de Duchenne. Com base na revisão das provas disponíveis, nos seus conhecimentos, na sua experiência clínica e nas características do sistema de saúde colombiano. As recomendações foram submetidas a uma votação (mais de 85% de favorabilidade em dois ciclos de votação). No caso de uma percentagem de concordância inferior à estabelecida, a recomendação foi novamente discutida, tendo sido efectuado um segundo ciclo de votação. Resultados e discussão: É emitida uma série de recomendações sobre a prescrição de ajudas técnicas na reabilitação (ortóteses e cadeiras de rodas) para doentes com distrofia muscular de Duchenne. São necessários mais estudos para resolver as questões que não foram respondidas até à data sobre a prescrição de ajudas técnicas em doentes com esta doença.

Sandra Castellar, Departamento Medicina física y Rehabilitación. Instituto Roosevelt y del Hospital Universitario Nacional de Colombia. Profesor titular. Universidad Nacional de Colombia. Bogotá, Colombia

Departamento Medicina física y Rehabilitación. Instituto Roosevelt. Bogotá, Colombia.

Departamento Medicina física y Rehabilitación. Hospital Universitario Nacional de Colombia. Bogotá, Colombia.

Profesor titular. Universidad Nacional de Colombia. Bogotá, Colombia

Edicson Ruiz-Ospina, Departamento Medicina física y Rehabilitación. Instituto Roosevelt y profesor titular. Universidad Nacional de Colombia. Bogotá, Colombia

Departamento Medicina física y Rehabilitación. Instituto Roosevelt. Bogotá, Colombia.

Profesor titular. Universidad Nacional de Colombia. Bogotá, Colombia

Miguel Ángel Gutiérrez-Ramírez, Profesor titular. Universidad Nacional de Colombia. Bogotá, Colombia

Profesor titular. Universidad Nacional de Colombia. Bogotá, Colombia

Sandy Arias-Hernández, Departamento de terapia Ocupacional. Instituto Roosevelt. Bogotá, Colombia.

Departamento de terapia Ocupacional. Instituto Roosevelt. Bogotá, Colombia.

Jhon Jairo Forero-Díaz, Departamento Medicina física y Rehabilitación y el Centro de investigación en fisiatría y electrodiagnóstico. Instituto Roosevelt. Bogotá, Colombia.

Departamento Medicina física y Rehabilitación. Instituto Roosevelt. Bogotá, Colombia.

Centro de investigación en fisiatría y electrodiagnóstico. Instituto Roosevelt. Bogotá, Colombia.

Fernando Ortiz-Corredor, Departamento Medicina física y Rehabilitación. Instituto Roosevelt y del  Hospital Universitario Nacional de Colombia. Bogotá, Colombia.

Departamento Medicina física y Rehabilitación. Instituto Roosevelt y del  Hospital Universitario Nacional de Colombia. Bogotá, Colombia.

Diana Soto-Peña, Coordinadora de Fisioterapia. Instituto Roosevelt. Bogotá, Colombia

Coordinadora de Fisioterapia. Instituto Roosevelt. Bogotá, Colombia

Paula Suárez-Castro, Junta de sedestación. Instituto Roosevelt. Bogotá, Colombia.

Junta de sedestación. Instituto Roosevelt. Bogotá, Colombia.

Laura Velásquez-Ballesteros, Departamento de Fisioterapia. Sanitas. Bogotá, Colombia.

Departamento de Fisioterapia. Sanitas. Bogotá, Colombia.

Francisco Zuluaga-Osorio, Centro Técnico Ortopédico LTDA. Bogotá, Colombia

Centro Técnico Ortopédico LTDA. Bogotá, Colombia

Castellar, S., Ruiz-Ospina, E. ., Gutiérrez-Ramírez, M. Ángel ., Arias-Hernández, S., Forero-Díaz, J. J. ., Ortiz-Corredor, F., … Zuluaga-Osorio, F. . (2025). Recomendações para a prescrição de dispositivos de assistência na reabilitação de doentes com distrofia muscular de Duchenne . Revista Ciencias De La Salud, 23(Especial), 1–19. https://doi.org/10.12804/revistas.urosario.edu.co/revsalud/a.13741

Bello L, Morgenroth LP, Gordish-Dressman H, Hoffman EP, McDonald CM, Cirak S. DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study. Neurology. 2016;87(4):401-9. DOI: 10.1212/WNL.0000000000002891. DOI: https://doi.org/10.1212/WNL.0000000000002891

Vandekerckhove I, De Beukelaer N, Van den Hauwe M, Shuman BR, Steele KM, Van Campenhout A, et al. Muscle weakness has a limited effect on motor control of gait in Duchenne muscular dystrophy. PloS one. 2020;15(9):e0238445. DOI: 10.1371/journal.pone.0238445. DOI: https://doi.org/10.1371/journal.pone.0238445

Gaudreault N, Gravel D, Nadeau S, Houde S. Motor function in Duchenne muscular dystrophy children: a review of the literature. Critical Reviews™ in Physical and Rehabilitation Medicine. 2005;17(3):231-248. DOI: 10.1615/CritRevPhysRehabilMed.v17.i3.50. DOI: https://doi.org/10.1615/CritRevPhysRehabilMed.v17.i3.50

Stevens PM. Lower limb orthotic management of Duchenne muscular dystrophy: a literature review. JPO: Journal of Prosthetics and Orthotics. 2006;18(4):111-9. DOI: 10.1016/s1071-9091(98)80024-7. DOI: https://doi.org/10.1097/00008526-200610000-00005

Kinali M, Main M, Mercuri E, Muntoni F. Evolution of abnormal postures in Duchenne muscular dystrophy. Annals of Indian Academy of Neurology. 2007;10(Suppl 1):S44-S54. DOI: https://doi.org/10.4103/0972-2327.33496

Archer JE, Gardner AC, Roper HP, Chikermane AA, Tatman AJ. Duchenne muscular dystrophy: the management of scoliosis. Journal of Spine Surgery. 2016;2(3):185-194. DOI: 10.21037/jss.2016.08.05. DOI: https://doi.org/10.21037/jss.2016.08.05

Ward LM, Hadjiyannakis S, McMillan HJ, Noritz G, Weber DR. Bone health and osteoporosis management of the patient with Duchenne muscular dystrophy. Pediatrics. 2018;142(Supplement_2):S34-S42. DOI: 10.1542/peds.2018-0333E. DOI: https://doi.org/10.1542/peds.2018-0333E

Buckner JL, Bowden SA, Mahan JD. Optimizing bone health in Duchenne muscular dystrophy. International Journal of Endocrinology. 2015;2015:928385. DOI: 10.1155/2015/928385. DOI: https://doi.org/10.1155/2015/928385

Aydın Yağcıoğlu G, Yılmaz Ö, Alemdaroğlu Gürbüz İ, Bulut N, Karaduman A, Özkal Ö, et al. Examination of the relationship between foot-body posture and balance and gait in Duchenne muscular dystrophy. Irish Journal of Medical Science. 2023;192 (4):1883-1888. DOI: 10.1007/s11845-022-03178-5. DOI: https://doi.org/10.1007/s11845-022-03178-5

Martini J, Voos MC, Hukuda ME, Resende MBDd, Caromano FA. Compensatory movements during functional activities in ambulatory children with Duchenne muscular dystrophy. Arquivos de neuro-psiquiatria. 2014;72:5-11. DOI: 10.1590/0004-282X20130196. DOI: https://doi.org/10.1590/0004-282X20130196

Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur AY. Corticosteroids for the treatment of Duchenne muscular dystrophy. Cochrane Database of Systematic Reviews. 2016(5). DOI: 10.1002/14651858.CD003725.pub4 DOI: https://doi.org/10.1002/14651858.CD003725.pub4

Mayo A, Craven B, McAdam L, Biggar W. Bone health in boys with Duchenne muscular dystrophy on long-term daily deflazacort therapy. Neuromuscular Disorders. 2012;22(12):1040-5. DOI: 10.1016/j.nmd.2012.06.354. DOI: https://doi.org/10.1016/j.nmd.2012.06.354

Rooney WD, Berlow YA, Triplett WT, Forbes SC, Willcocks RJ, Wang D-J, et al. Modeling disease trajectory in Duchenne muscular dystrophy. Neurology. 2020;94(15):e1622-e33. DOI: 10.1212/WNL.0000000000009244. DOI: https://doi.org/10.1212/WNL.0000000000009244

Korinthenberg R. A new era in the management of Duchenne muscular dystrophy. Developmental Medicine & Child Neurology. 2019;61(3):292-7. DOI: 10.1111/dmcn.14129. DOI: https://doi.org/10.1111/dmcn.14129

Case LE, Apkon SD, Eagle M, Gulyas A, Juel L, Matthews D, et al. Rehabilitation management of the patient with Duchenne muscular dystrophy. Pediatrics. 2018;142(Supplement_2):S17-S33. DOI: 10.1542/peds.2018-0333D. DOI: https://doi.org/10.1542/peds.2018-0333D

Swiderski K, Hardee JP, Lynch GS. Regenerative Rehabilitation for Duchenne Muscular Dystrophy. Regenerative Rehabilitation: From Basic Science to the Clinic: Springer; 2022. p. 85-119. DOI: https://doi.org/10.1007/978-3-030-95884-8_4

Araujo AP, Nardes F, Fortes CP, Pereira JA, Rebel MF, Dias CM, et al. Brazilian consensus on Duchenne muscular dystrophy. Part 2: rehabilitation and systemic care. Arquivos de Neuro-Psiquiatria. 2018;76:481-9. DOI: 10.1590/0004-282X20180062. DOI: https://doi.org/10.1590/0004-282x20180062

Alemdaroğlu I, Karaduman A, Yilmaz ÖT, Topaloğlu H. Different types of upper extremity exercise training in Duchenne muscular dystrophy: effects on functional performance, strength, endurance, and ambulation. Muscle & nerve. 2015;51(5):697-705. DOI: 10.1002/mus.24451. DOI: https://doi.org/10.1002/mus.24451

Choi Y-A, Shin H-I, Shin HI. Scoliosis in Duchenne muscular dystrophy children is fully reducible in the initial stage, and becomes structural over time. BMC musculoskeletal disorders. 2019;20(1):277. DOI: 10.1186/s12891-019-2661-6. DOI: https://doi.org/10.1186/s12891-019-2661-6

Denger B, Kinnett K, Martin A, Grant S, Armstrong C, Khodyakov D. Patient and caregiver perspectives on guideline adherence: the case of endocrine and bone health recommendations for Duchenne muscular dystrophy. Orphanet Journal of Rare Diseases. 2019;14(1):205. DOI: 10.1186/s13023-019-1173-7 DOI: https://doi.org/10.1186/s13023-019-1173-7

Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. The Lancet Neurology. 2018;17(3):251-67. DOI: 10.1016/S1474-4422(18)30024-3. DOI: https://doi.org/10.1016/S1474-4422(18)30024-3

Pangalila RF, Van Den Bos GA, Bartels B, Bergen MP, Kampelmacher MJ, Stam HJ, et al. Quality of life of adult men with Duchenne muscular dystrophy in the Netherlands: implications for care. Journal of rehabilitation medicine. 2015;47(2):161-6. DOI: 10.2340/16501977-1898. DOI: https://doi.org/10.2340/16501977-1898

Bray P, Bundy AC, Ryan MM, North KN, Everett A. Health-related quality of life in boys with Duchenne muscular dystrophy: agreement between parents and their sons. Journal of child neurology. 2010;25(10):1188-94. DOI: 10.1177/0883073809357624. DOI: https://doi.org/10.1177/0883073809357624

Wasilewska E, Małgorzewicz S, Sobierajska-Rek A, Jabłońska-Brudło J, Górska L, Śledzińska K, et al. Transition from childhood to adulthood in patients with Duchenne muscular dystrophy. Medicina. 2020;56(9):426. DOI: 10.3390/medicina56090426. DOI: https://doi.org/10.3390/medicina56090426

Andrews JG, Wahl RA. Duchenne and Becker muscular dystrophy in adolescents: current perspectives. Adolescent health, medicine and therapeutics. 2018:53-63. DOI: 10.2147/AHMT.S125739. DOI: https://doi.org/10.2147/AHMT.S125739

Messina S, Vita GL. Clinical management of Duchenne muscular dystrophy: the state of the art. Neurological Sciences. 2018;39:1837-45. DOI: 10.1007/s10072-018-3555-3. DOI: https://doi.org/10.1007/s10072-018-3555-3

Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. The Lancet Neurology. 2010;9(2):177-89. DOI: 10.1016/S1474-4422(09)70272-8. DOI: https://doi.org/10.1016/S1474-4422(09)70272-8

López EM, Cardós MTG, Medina CCH, Pelarda ACV, Gil LS, García MMS. Introducción multidisciplinar a la distrofia muscular de Duchenne. Revista Sanitaria de Investigación. 2021;2(9):156.

Rivas MM, Leones SMC, Ospina ER, Ruiz DMC, Echeverri RC, Arango MEM, et al. Consenso colombiano para el seguimiento de pacientes con Distrofia muscular de Duchenne. Pediatría. 2019;52(3):75-84.

Apkon SD, Alman B, Birnkrant DJ, Fitch R, Lark R, Mackenzie W, et al. Orthopedic and surgical management of the patient with Duchenne muscular dystrophy. Pediatrics. 2018;142(Supplement_2):S82-S9. DOI: 10.1542/peds.2018-0333J. DOI: https://doi.org/10.1542/peds.2018-0333J

Webster JB, Murphy DP. Atlas of Orthoses and Assistive Devices. %th Edition. Elsevier Health Sciences. 2017. ISBN: 9780323483230.

Febrer A, Meléndez M, Fadol L. Estudio sobre ayudas técnicas en la distrofia muscular de Duchenne. Rehabilitación. 2001;35(1):20-7. DOI: https://doi.org/10.1016/S0048-7120(01)73131-3

Osorio AN, Cantillo JM, Salas AC, Garrido MM, Padilla JV. Consensus on the diagnosis, treatment and follow-up of patients with Duchenne muscular dystrophy. Neurología. 2019;34(7):469-81. DOI: 10.1016/j.nrl.2018.01.001 DOI: https://doi.org/10.1016/j.nrleng.2018.01.001

Bakker J, De Groot I, De Jong B, Van Tol-De Jager M, Lankhorst G. Prescription pattern for orthoses in the Netherlands: use and experience in the ambulatory phase of Duchenne muscular dystrophy. Disability and rehabilitation. 1997;19(8):318-25. DOI: 10.3109/09638289709166545. DOI: https://doi.org/10.3109/09638289709166545

Lovegreen W, Pai AB. Orthoses for the Muscle Disease Patient. Atlas of Orthoses and Assistive Devices. 5th Edition. Elsevier; 2019. p. 332-6. e1. Doi:10.1016/B978-0-323-48323-0.00032-9. DOI: https://doi.org/10.1016/B978-0-323-48323-0.00032-9

OKÇU M, TUNCAY F, KOÇAK FA, DOĞRU YG, KARAKUZU GÜNGÖR Z, KAYA SS. Factors Affecting Compliance with Lower and Upper Extremity Orthoses in Patients with Disability Due to Neurological Diseases. Journal of Physical Medicine & Rehabilitation Sciences. 2022;25(2). DOI: 10.31609/jpmrs.2021-86851. DOI: https://doi.org/10.31609/jpmrs.2021-86851

Bakker J, De Groot I, Beckerman H, De Jong B, Lankhorst G. The effects of knee-ankle-foot orthoses in the treatment of Duchenne muscular dystrophy: review of the literature. Clinical rehabilitation. 2000;14(4):343-59. DOI: 10.1191/0269215500cr319oa. DOI: https://doi.org/10.1191/0269215500cr319oa

de Souza MA, Figueiredo MML, Aldaves RD, Mattiello-Sverzut AC. Beneficial effects of ankle–foot orthosis daytime use on the gait of Duchenne muscular dystrophy patients. Clinical Biomechanics. 2016;35:102-10. DOI: 10.1016/j.clinbiomech.2016.04.005. DOI: https://doi.org/10.1016/j.clinbiomech.2016.04.005

Corredor FO, Roncancio MR, Pulido JCM. Texto de medicina física y rehabilitación. 1° Edición. Editorial El Manual Moderno.2016. ISBN 9789588993034.

Weichbrodt J, Eriksson B-M, Kroksmark A-K. Evaluation of hand orthoses in Duchenne muscular dystrophy. Disability and rehabilitation. 2018;40(23):2824-32. DOI: 10.1080/09638288.2017.1347721. DOI: https://doi.org/10.1080/09638288.2017.1347721

Haarman C. Development of a functional hand orthosis for boys with Duchenne muscular dystrophy. University of Twente. 2016.

Bergsma A, Lobo-Prat J, Vroom E, Furlong P, Herder JL, Corrigan M, et al. 1st workshop on upper-extremity assistive technology for people with duchenne: State of the art, emerging avenues, and challenges: April 27th 2015, london, united kingdom. Neuromuscular disorders. 2016;26(6):386-93. DOI: 10.1016/j.nmd.2016.04.005. DOI: https://doi.org/10.1016/j.nmd.2016.04.005

Mahmood MN, Peeters LH, Paalman M, Verkerke GJ, Kingma I, Van Dieën JH. Development and evaluation of a passive trunk support system for Duchenne muscular dystrophy patients. Journal of neuroengineering and rehabilitation. 2018;15 (1):22. DOI: 10.1186/s12984-018-0353-3. DOI: https://doi.org/10.1186/s12984-018-0353-3

Kotwicki T, Durmala J, Czubak J. Bracing for neuromuscular scoliosis: orthosis construction to improve the patient's function. Disability and Rehabilitation: Assistive Technology. 2008;3(3):161-9. DOI: 10.1080/17483100801905900. DOI: https://doi.org/10.1080/17483100801905900

Roberts SB, Tsirikos AI. Factors influencing the evaluation and management of neuromuscular scoliosis: A review of the literature. Journal of back and musculoskeletal rehabilitation. 2016;29(4):613-23. DOI: 10.3233/BMR-160675. DOI: https://doi.org/10.3233/BMR-160675

Harvey A, Baker L, Williams K. Non‐surgical prevention and management of scoliosis for children with Duchenne muscular dystrophy: What is the evidence? Journal of Paediatrics and Child Health. 2014;50(10):E3-E9. DOI: 10.1111/jpc.12177. DOI: https://doi.org/10.1111/jpc.12177

Akbarnia BA, Thompson GH, Yazici M, Hawary R. The Growing Spine: Management of Spinal Disorders in Young Children.3rd Edition. Springer Cham.2022:171-82. Doi:10.1007/978-3-030-84393-9. DOI: https://doi.org/10.1007/978-3-030-84393-9

LoMauro A, D’Angelo MG, Aliverti A. Assessment and management of respiratory function in patients with Duchenne muscular dystrophy: current and emerging options. Therapeutics and clinical risk management. 2015:1475-88. DOI: 10.2147/TCRM.S55889. DOI: https://doi.org/10.2147/TCRM.S55889

Chua K, Lau L-L, Hui JHP, Lee EH. Neuromuscular scoliosis: how decision making and treatment are different. Current Orthopaedic Practice. 2017;28(1):3-9. DOI: 10.1097/BCO.0000000000000464 DOI: https://doi.org/10.1097/BCO.0000000000000464

Bell JM, Shields MD, Watters J, Hamilton A, Beringer T, Elliott M, et al. Interventions to prevent and treat corticosteroid‐induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy. Cochrane Database of Systematic Reviews. 2017(1): CD010899. DOI: 10.1002/14651858.CD010899.pub2. DOI: https://doi.org/10.1002/14651858.CD010899.pub2

Pandya S, Andrews J, Campbell K, Meaney FJ. Rehabilitative technology use among individuals with Duchenne/Becker muscular dystrophy. Journal of pediatric rehabilitation medicine. 2016;9(1):45-53. DOI: 10.3233/PRM-160356. DOI: https://doi.org/10.3233/PRM-160356

Arman S. What is the effect of assistive devices for standing in the rehabilitation of patients with Duchenne muscular dystrophy? A Cochrane Review summary with commentary. Developmental Medicine & Child Neurology. 2020;62(12):1350-1. DOI: 10.1111/dmcn.14699. DOI: https://doi.org/10.1111/dmcn.14699

Pedlow K, McDonough S, Lennon S, Kerr C, Bradbury I. Assisted standing for Duchenne muscular dystrophy. Cochrane Database of Systematic Reviews. 2019; 10(10):CD011550. DOI: 10.1002/14651858.CD011550.pub2. DOI: https://doi.org/10.1002/14651858.CD011550.pub2

Rose K, Burns J, Wheeler D, North K. Interventions for increasing ankle flexibility in patients with neuromuscular disease. Cochrane Database Systematic Review. 2010;17(2):CD006973. DOI: 10.1002/14651858.CD006973.pub2. DOI: https://doi.org/10.1002/14651858.CD006973.pub2

Mannlein J, Pangilinan PH. Wheelchair seating for children with Duchenne Muscular Dystrophy. Journal of pediatric rehabilitation medicine. 2008;1(3):225-35. DOI: https://doi.org/10.3233/PRM-2008-00043

Winter A, Hotchkiss R. Mechanical principles of wheelchair design. USA: Massachusetts Institute of Technology. 2010.

randt, Å., Samuelsson, K. (2009). Wheelchair Intervention: Principles and Practice. In: Söderback, I. (eds) International Handbook of Occupational Therapy Interventions. Springer, New York, NY. https://doi.org/10.1007/978-0-387-75424-6_8 DOI: https://doi.org/10.1007/978-0-387-75424-6_8

Calderón MVO, Pineda ODP. Silla de ruedas. Texto de medicina física y rehabilitación. 2022:442.

Moody L, Woodcock A, Heelis M, Chichi C, Fielden S, Stefanov D. Improving wheelchair prescription: an analysis of user needs and existing tools. Work. 2012;41(Supplement 1):1980-4. DOI: 10.3233/WOR-2012-0418-1980. DOI: https://doi.org/10.3233/WOR-2012-0418-1980

Batavia M. The wheelchair evaluation: A clinician's guide. 2nd Edition. Jones & Bartlett Publishers. 2010. ISBN:9780763761721.

Pellichero A, Routhier F, Sorita É, Archambault PS, Demers L, Best KL. Consensus for a power wheelchair training approach for people with cognitive impairments. Disability and Rehabilitation: Assistive Technology. 2023;18(1):109-17. DOI: 10.1080/17483107.2022.2120100. DOI: https://doi.org/10.1080/17483107.2022.2120100

Schofield C, Evans K, Young H, Paguinto S, Carroll K, Townsend E, et al. The development of a consensus statement for the prescription of powered wheelchair standing devices in Duchenne muscular dystrophy. Disability and Rehabilitation. 2022;44(10):1889-97. DOI: 10.1080/09638288.2020.1810786. DOI: https://doi.org/10.1080/09638288.2020.1810786

Livingstone R, Paleg G. Practice considerations for the introduction and use of power mobility for children. Developmental Medicine & Child Neurology. 2014;56(3):210-21. DOI: 10.1111/dmcn.12245 DOI: https://doi.org/10.1111/dmcn.12245

Vorster N, Evans K, Murphy N, Kava M, Cairns A, Clarke D, et al. Powered standing wheelchairs promote independence, health and community involvement in adolescents with Duchenne muscular dystrophy. Neuromuscular Disorders. 2019;29(3):221-30. DOI: 10.1016/j.nmd.2019.01.010. DOI: https://doi.org/10.1016/j.nmd.2019.01.010

Tanabe A, Fujiwara T, Tanuma A, Liu M. The relationship between wheelchair type and impairments among patients with Duchenne Muscular Dystrophy. The Japanese Journal of Rehabilitation Medicine. 2007:685-9. DOI: https://doi.org/10.2490/jjrmc.44.685

Rodini CO, Collange LA, Juliano Y, Oliveira CS, Isola AM, Almeida SB, et al. Influence of wheelchair positioning aids on the respiratory function of patients with Duchenne muscular dystrophy. Fisioterapia e Pesquisa. 2012;19:97-102. DOI:10.1590/S1809-29502012000200002. DOI: https://doi.org/10.1590/S1809-29502012000200002

Young H. Powered Wheelchair Standing devices impact on participation for boys with Duchenne Muscular Distrophy. University of Sydney. 2021.

Muñoz Rivas MR, Lasso Largo CI, Kestenberg Buitrago C. Guía de práctica clínica para la detección temprana, manejo y rehabilitación de usuarios con diagnóstico de distrofia muscular (adopción).Fundación Ideal. 2023. ISBN: 978-628-95496-0-7.

Rivas MM, Castellar Leones SM, Ruiz Ospina E, Chaustre Ruiz D, Miño Arango ME, Rodriguez BD, et al.Consenso Colombiano para el seguimiento de pacientes con Distrofia muscular de Duchenne. Revista Pediatría. 2019;52(3). DOI:10.14295/p.v52i3.153. DOI: https://doi.org/10.14295/p.v52i3.153

Lugo Agudelo LH, Seijas Bermúdez VA, Salinas Durán FA, Quintero Valencia CA, Acosta Baena N, Rodríguez Guevara C. Tratamiento quirúrgico y de rehabilitación de las Distrofias Musculares. Recomendaciones basadas en la evidencia para la Guía de Práctica Clínica en Colombia. 2016; 29 (4-S2). DOI:10.17533/udea.iatreia.26863.

McDonald CM, Carter GT, Han JJ, Benditt JO. Rehabilitation management of Duchenne muscular dystrophy. Duchenne Muscular Dystrophy. CRC Press. 2006:177-204.ISBN: 9780824723255. DOI: https://doi.org/10.3109/9780849374456-11

Lindsay S, McAdam L, Mahendiran T. Enablers and barriers of men with Duchenne muscular dystrophy transitioning from an adult clinic within a pediatric hospital. Disability and Health Journal. 2017;10(1):73-9. DOI: 10.1016/j.dhjo.2016.10.002. DOI: https://doi.org/10.1016/j.dhjo.2016.10.002

Conway K, Trout C, Westfield C, Fox D, Pandya S. A pilot survey study of adherence to care considerations for Duchenne muscular dystrophy. PLoS Currents. 2018;10. DOI: 10.1371/currents.md.5f533e6e60ee172d6bf6b2b8375dfadf. DOI: https://doi.org/10.1371/currents.md.5f533e6e60ee172d6bf6b2b8375dfadf

Clinard K. Research participation in the Duchenne muscular dystrophy community: parent perceived barriers and their impact on families. University of Pittsburgh. 2012.

Bermúdez Bayón U. Características del ocio en personas con distrofia muscular de Duchenne, facilitadores y barreras, según la CIF. 2013.

Goemans N, Signorovitch J, McDonald C, Mercuri E, Niks E, Wong B, et al., editors. Functional trajectories of upper limb and pulmonary function before and after loss of ambulation in Duchenne muscular dystrophy. Muscular Dystrophy Association Clinical & Scientific Conference. 2020.

McDonald CM, Henricson EK, Abresch RT, Han JJ, Escolar DM, Florence JM, et al. The cooperative international neuromuscular research group Duchenne natural history study—a longitudinal investigation in the era of glucocorticoid therapy: design of protocol and the methods used. Muscle & nerve. 2013;48(1):32-54. DOI:10.1002/mus.23807. DOI: https://doi.org/10.1002/mus.23807

Coratti G, Brogna C, Norcia G, Ricotti V, Abbott L, D'Amico A, et al. Longitudinal natural history in young boys with Duchenne muscular dystrophy. Neuromuscular Disorders. 2019;29(11):857-62. DOI: 10.1016/j.nmd.2019.09.010. DOI: https://doi.org/10.1016/j.nmd.2019.09.010

McDonald CM, Henricson EK, Abresch RT, Florence J, Eagle M, Gappmaier E, et al. The 6‐minute walk test and other clinical endpoints in Duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study. Muscle & nerve. 2013;48(3):357-68. DOI: 10.1002/mus.23905. DOI: https://doi.org/10.1002/mus.23905

Miller NF, Alfano LN, Iammarino MA, Connolly AM, Moore-Clingenpeel M, Powers BR, et al. Natural history of steroid-treated young boys with Duchenne muscular dystrophy using the NSAA, 100m, and timed functional tests. Pediatric Neurology. 2020;113:15-20. DOI: 10.1016/j.pediatrneurol.2020.08.013. DOI: https://doi.org/10.1016/j.pediatrneurol.2020.08.013

Kamaraj DC, Dicianno BE, Cooper RA. A participatory approach to develop the power mobility screening tool and the power mobility clinical driving assessment tool. BioMed research international. 2014;2014:541614. DOI: 10.1155/2014/541614. DOI: https://doi.org/10.1155/2014/541614

Dawson DR, Kaiserman-Goldenstein E, Chan R, Gleason J. Power-mobility indoor driving assessment manual (PIDA). Toronto (Canada): Department of Occupational Therapy, Sunnybrook and Women’s College Health Sciences Centre. 2006.

Downloads

Não há dados estatísticos.

Artigos mais lidos pelo mesmo(s) autor(es)

Artigos Semelhantes

1 2 3 4 5 6 7 8 9 > >> 

Você também pode iniciar uma pesquisa avançada por similaridade para este artigo.